Mushroom-infused RECALL ‘microdosing’ chocolate bars after hospitalizations: FDA

Share

“According to the firm, these products contain muscimol, a chemical found in some mushrooms, that could be a potential cause of symptoms consistent with some symptoms observed in individuals who became ill after consuming Diamond Shruumz-brand products,” the FDA’s press release read.

“FDA is evaluating this information.”

In a statement released Friday, the FDA explained that Prophet Premium Blends, a distributor of Diamond Shruumz products, recalled the company’s products Thursday.

The FDA also disclosed that chemical tests of two Diamond Shruumz products found the presence of a psychoactive drug called O-acetylpsilocin, or psilacetin. 

Both the company’s Dark Chocolate Bar and Birthday Cake Chocolate Bar allegedly contained the substance.

Diamond Shruumz’s Dark Chocolate Bar also contained desmethoxyyangonin, dihydrokavain and kavain. The FDA disclosed that its investigation of these products is still ongoing.

“FDA and CDC medical officers are interpreting these test results to understand the health risks of ingesting these chemical substances and to determine the appropriate next steps,” the FDA said.

There have now been 39 illnesses linked to the products, including 23 hospitalizations.

The sweets have reportedly caused symptoms ranging from seizures to nausea.

According to Diamond Shruumz’s website, the “microdosing” products are not intended to be psychedelic and do not contain psilocybin. “Microdosing” usually refers to taking very small amounts of psychedelic drugs.

“There is no presence of psilocybin, amanita or any scheduled drugs, ensuring a safe and enjoyable experience,” the company claims.

“Rest assured, our treats are not only free from psychedelic substances, but our carefully crafted ingredients still offer an experience.”

Read More